BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3. A total of 19 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $17,825,000 | +16.0% | 5,000,000 | 0.0% | 0.01% | +10.0% |
| Q2 2014 | $15,365,000 | -8.7% | 5,000,000 | 0.0% | 0.01% | -16.7% |
| Q1 2014 | $16,830,000 | -3.2% | 5,000,000 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $17,385,000 | -3.2% | 5,000,000 | 0.0% | 0.01% | -7.7% |
| Q3 2013 | $17,960,000 | – | 5,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLG Partners LP | 18,250,000 | $50,831,000 | 1.94% |
| MACKAY SHIELDS LLC | 9,117,000 | $25,277,000 | 1.35% |
| Baker Brothers Advisors | 22,898,000 | $63,217,000 | 1.25% |
| Amici Capital, LLC | 8,000,000 | $22,185,000 | 0.81% |
| Verition Fund Management LLC | 1,075,000 | $2,981,000 | 0.55% |
| Pine River Capital Management L.P. | 4,700,000 | $13,089,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,000,000 | $5,570,000 | 0.16% |
| SYMPHONY ASSET MANAGEMENT LLC | 324,000 | $898,000 | 0.09% |
| AVIVA PLC | 2,000,000 | $5,615,000 | 0.06% |
| Cheyne Capital Management (UK) LLP | 2,000,000 | $74,000 | 0.05% |